主持完成國家自然科學(xué)基金1項(xiàng)(非小細(xì)胞肺癌OPN對(duì)TAM的功能調(diào)控研究編號(hào)81201649),；
主持完成天津市科委1項(xiàng)(OPN/CD44在非小細(xì)胞肺癌轉(zhuǎn)移中的作用及機(jī)制編號(hào)11JCYBJC13300),；
主持完成教育部高等學(xué)校博士學(xué)科點(diǎn)專項(xiàng)科研基金(OPN/CD44信號(hào)通路對(duì)非小細(xì)胞肺癌的趨化作用及機(jī)制編號(hào)20101202120004),；
發(fā)表學(xué)術(shù)論文10余篇,，部分成果先后發(fā)表在《Ann Thorac Surg 》和《J Thorac Cardiovasc Surg》等胸外科權(quán)威期刊,。
近5年發(fā)表文章SCI論文：
1.Osteopontin combined with CD44v6, a novel prognostic biomarker in non-small cell lung cancer undergoing curative resection.Ann Thorac Surg.2013 Dec;96(6):1943-51.
2.Interstitial tumor-associated macrophages combined with tumor-derived colony-stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2014 May 9.
3. Osteopontin-expressing macrophages in non-small cell lung cancer predict survival. Ann Thorac Surg. 2015 Apr;99(4):1140-8. doi: 10.1016/j.athoracsur.2014.11.054. Epub 2015 Feb 26.
4.Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis. Chin Med J (Engl). 2013;126(9):1683-8.
5.Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients. World J Surg. 2012,36(2):455-62.
6.CCR1 knockdown suppresses human non-small cell lung cancer cell invasion, J Cancer Res Clin Oncol. 2009 May;135(5):695-701.
7.Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH. J Cancer Res Clin Oncol. 2010,136:595-601.
|
